Peptides and growth factors represent among the most expensive and most marketed ingredients in anti-aging skincare — and also among the most scientifically plausible. Unlike some cosmetic ingredient categories where proposed mechanisms are implausible (ingredients too large to penetrate the SC, or present in concentrations far too low for biological activity), certain peptides have robust in vitro evidence and a growing body of clinical trial data. The challenge for clinicians and consumers is distinguishing evidence-supported peptides from the vast category of "peptide-containing" products where concentrations, formulation, and delivery are insufficient for biological activity.
Signal Peptides: Collagen Synthesis Stimulation
Signal peptides trigger collagen and elastin synthesis by binding to receptors on dermal fibroblasts, mimicking matrikine signaling (TGF-β and other collagen synthesis regulators). The most studied: Matrixyl (palmitoyl pentapeptide-4) — a lipidated pentapeptide that has demonstrated collagen I, III, and fibronectin synthesis stimulation in fibroblast cultures and modest wrinkle reduction (approximately 20% depth reduction by profilometry) in a 12-week RCT. Matrixyl 3000 (palmitoyl tetrapeptide-7 + palmitoyl oligopeptide) — follow-up formulation with evidence of pro-collagen and elastin synthesis. Leuphasyl (pentapeptide-18) — Botox-mimicking signal peptide theoretically reducing muscle contraction via acetylcholine vesicle fusion inhibition (in vitro evidence; clinical translation of anti-wrinkle effect is modest).
Carrier Peptides: Copper Peptides
GHK-Cu (copper tripeptide-1) — the best-studied carrier peptide — delivers copper to lysyl oxidase, the enzyme required for cross-linking collagen and elastin fibers. Evidence: GHK-Cu at 1–4% in controlled studies increased dermal thickness and collagen density, reduced fine wrinkles, and produced anti-inflammatory effects — making it a multi-mechanism anti-aging ingredient with genuine clinical promise. GHK-Cu has also demonstrated wound healing acceleration in clinical studies relevant to post-procedure skin recovery. Our skin care catalog includes copper peptide-containing products for clinical use.
Growth Factors: Biological Activity, Regulatory Questions
Epidermal growth factor (EGF), TGF-β, IGF-1, and other growth factors applied topically stimulate fibroblast proliferation and collagen synthesis in in vitro models. The clinical controversy: molecular weight of most growth factors (>6000 Da) exceeds SC penetration threshold for intact skin. Delivery via microchannels (immediately post-microneedling), nano-emulsion vehicles, or exosome encapsulation may improve penetration. Clinical trials of topical growth factor-containing products have shown improvements in photoaging measures — though many are industry-sponsored with small sample sizes. EGF-containing products applied post-microneedling have the strongest evidence base for synergistic benefit compared to standalone topical application.
